In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 14th, 2009 | 34 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.08 | 9.8 | -17.86 | 4 | 7 | 0 | 103 | 500.361 | 7 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AURKA-1-E | Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic | Eukaryotes | 540 | 0.26 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 852 | 0.25 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.24 | Binding ≤ 10μM |
M3K7-1-E | Mitogen-activated Protein Kinase Kinase Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.23 | Binding ≤ 10μM |
MK01-1-E | Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.36 | Binding ≤ 10μM |
MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.24 | Binding ≤ 10μM |
ROCK1-1-E | Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.24 | Binding ≤ 10μM |
Z80166-1-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other | Other | 48 | 0.30 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 852 | 0.25 | Binding ≤ 1μM |
MK01_HUMAN | P28482 | MAP Kinase ERK2, Human | 2 | 0.36 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 540 | 0.26 | Binding ≤ 1μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 1400 | 0.24 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 852 | 0.25 | Binding ≤ 10μM |
MK01_HUMAN | P28482 | MAP Kinase ERK2, Human | 2 | 0.36 | Binding ≤ 10μM |
M3K7_HUMAN | O43318 | Mitogen-activated Protein Kinase Kinase Kinase 7, Human | 3000 | 0.23 | Binding ≤ 10μM |
ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 1400 | 0.24 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 540 | 0.26 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1400 | 0.24 | Binding ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 48 | 0.30 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of ATR in response to replication stress | |
Activation of NF-kappaB in B cells | |
Activation of the AP-1 family of transcription factors | |
Activation of the pre-replicative complex | |
Advanced glycosylation endproduct receptor signaling | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Apoptotic cleavage of cellular proteins | |
Ca2+ pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
CREB phosphorylation through the activation of Ras | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream TCR signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK/MAPK targets | |
ERK2 activation | |
ERKs are inactivated | |
Factors involved in megakaryocyte development and platelet production | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
G alpha (12/13) signalling events | |
G0 and Early G1 | |
G2 Phase | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
Growth hormone receptor signaling | |
Interleukin-1 signaling | |
IRAK2 mediated activation of TAK1 complex | |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Meiotic recombination | |
NCAM signaling for neurite out-growth | |
Negative regulation of FGFR signaling | |
NOD1/2 Signaling Pathway | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
phospho-PLA2 pathway | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of PLK1 Activity at G2/M Transition | |
RSK activation | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Sema4D induced cell migration and growth-cone collapse | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signal attenuation | |
Signal transduction by L1 | |
Signaling by FGFR | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
Thrombin signalling through proteinase activated receptors (PARs) | |
TRAF6 mediated induction of TAK1 complex | |
VEGFA-VEGFR2 Pathway |